Qualisure Diagnostics Inc. develops molecular diagnostic tests that enhance cancer care through early detection, improving diagnostic precision, and facilitating individualization of treatments. Our biomarkers and algorithms are designed to make cancer screening easier and more convenient for the patient; to guide decision making for oncologists; and to drive cost savings for the healthcare system. Each of our biomarkers is designed to influence clinical decision making and to facilitate Precision Medicine.
